Arecor Therapeutics

Arecor Therapeutics company information, Employees & Contact Information

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary formulation technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced formulations of their therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.

Company Details

Employees
34
Founded
-
Address
Arecor Ltd, Chesterford Research Park, Little Chesterford,united Kingdom
Phone
441223426060
Email
in****@****cor.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
arecor.com
HQ
Cambridge, Cambridgeshire
Looking for a particular Arecor Therapeutics employee's phone or email?

Arecor Therapeutics Questions

News

Skye Bioscience Establishes Partnership with Arecor - GlobeNewswire

Skye Bioscience Establishes Partnership with Arecor GlobeNewswire

Skye Bioscience Partners with Arecor Therapeutics to Enhance Nimacimab Formulation for Obesity Treatment - Quiver Quantitative

Skye Bioscience Partners with Arecor Therapeutics to Enhance Nimacimab Formulation for Obesity Treatment Quiver Quantitative

New Obesity Drug Breakthrough: Skye Bioscience's Once-Weekly Treatment Gets Powerful Upgrade - Stock Titan

New Obesity Drug Breakthrough: Skye Bioscience's Once-Weekly Treatment Gets Powerful Upgrade Stock Titan

Sequel Med Tech, Arecor ink co-development agreement for ultra-rapid insulin with twiist - Drug Delivery Business

Sequel Med Tech, Arecor ink co-development agreement for ultra-rapid insulin with twiist Drug Delivery Business

Skye and Arecor to develop higher formulation of CB1 inhibitor - Pharmaceutical Technology

Skye and Arecor to develop higher formulation of CB1 inhibitor Pharmaceutical Technology

Sequel Med Tech taps Arecor to test its twiist pump with ultraconcentrated insulin - Fierce Biotech

Sequel Med Tech taps Arecor to test its twiist pump with ultraconcentrated insulin Fierce Biotech

Arecor and Sequel to Co-Develop Next-Generation Insulin Delivery - HIT Consultant

Arecor and Sequel to Co-Develop Next-Generation Insulin Delivery HIT Consultant

Arecor Partners with Sequel for Advanced Insulin Delivery, Secures $11M Funding - TipRanks

Arecor Partners with Sequel for Advanced Insulin Delivery, Secures $11M Funding TipRanks

Arecor shares soar on US-rooted $11m financing and key drug alliance - Business Weekly

Arecor shares soar on US-rooted $11m financing and key drug alliance Business Weekly

LGND: Ligand Pharmaceuticals Inks $11M Royalty Deal with Arecor - GuruFocus

LGND: Ligand Pharmaceuticals Inks $11M Royalty Deal with Arecor GuruFocus

Skye Bioscience Partners With Arecor: Potentially Enhanced Nimacimab Dosing (NASDAQ:SKYE) - Seeking Alpha

Skye Bioscience Partners With Arecor: Potentially Enhanced Nimacimab Dosing (NASDAQ:SKYE) Seeking Alpha

Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million - Cambridge Network

Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million Cambridge Network

Arecor surges 31% on US insulin after it increases cash runway with $11m deal - Proactive Investors

Arecor surges 31% on US insulin after it increases cash runway with $11m deal Proactive Investors

Arecor Therapeutics shares advance within FTSE All Share as healthcare sector activity remains steady - Kalkine Media

Arecor Therapeutics shares advance within FTSE All Share as healthcare sector activity remains steady Kalkine Media

Arecor Therapeutics And 2 Other UK Penny Stocks To Consider - simplywall.st

Arecor Therapeutics And 2 Other UK Penny Stocks To Consider simplywall.st

Arecor Therapeutics extends cash runway with US partnerships - The Armchair Trader

Arecor Therapeutics extends cash runway with US partnerships The Armchair Trader

Arecor announces positive FDA feedback on Phase 2 clinical study design for AT278 in an AID system - Cambridge Network

Arecor announces positive FDA feedback on Phase 2 clinical study design for AT278 in an AID system Cambridge Network

Arecor strikes US partnership for insulin pump, brings in up to $11m in royalty deal - Proactive Investors

Arecor strikes US partnership for insulin pump, brings in up to $11m in royalty deal Proactive Investors

Arecor stock plummets after Tetris retreat - Business Weekly

Arecor stock plummets after Tetris retreat Business Weekly

Arecor sells Tetris assets as it narrows focus on core drug pipeline - Proactive Investors

Arecor sells Tetris assets as it narrows focus on core drug pipeline Proactive Investors

AIM Market Roundup: The Revel Collective, Tanfield, Arecor - The Armchair Trader

AIM Market Roundup: The Revel Collective, Tanfield, Arecor The Armchair Trader

Companies Like Arecor Therapeutics (LON:AREC) Are In A Position To Invest In Growth - Yahoo Finance

Companies Like Arecor Therapeutics (LON:AREC) Are In A Position To Invest In Growth Yahoo Finance

Arecor Announces an Exclusive Formulation Study Collaboration With Lilly - GlobeNewswire

Arecor Announces an Exclusive Formulation Study Collaboration With Lilly GlobeNewswire

Medtronic, Arecor team up to develop insulin for implantable pumps - Drug Delivery Business

Medtronic, Arecor team up to develop insulin for implantable pumps Drug Delivery Business

Is Arecor Therapeutics plc (6UI) stock expanding market penetration - July 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - Trung tâm Dự báo KTTV quốc gia

Is Arecor Therapeutics plc (6UI) stock expanding market penetration - July 2025 WrapUp & Stepwise Entry/Exit Trade Alerts Trung tâm Dự báo KTTV quốc gia

Arecor Therapeutics adds diabetes product to portfolio after significant acquisition - Labiotech.eu

Arecor Therapeutics adds diabetes product to portfolio after significant acquisition Labiotech.eu

Arecor targets $3bn diabetes market with AT278 - One2One Investor Forum - Proactive financial news

Arecor targets $3bn diabetes market with AT278 - One2One Investor Forum Proactive financial news

Arecor, Medtronic Diabetes Collaborate on Thermostable Insulin - Medical Product Outsourcing

Arecor, Medtronic Diabetes Collaborate on Thermostable Insulin Medical Product Outsourcing

Roquefort Therapeutics, Arecor Therapeutics, EMV Capital, IQ-AI, Ariana Resources - Small Cap Snapshot - Proactive financial news

Roquefort Therapeutics, Arecor Therapeutics, EMV Capital, IQ-AI, Ariana Resources - Small Cap Snapshot Proactive financial news

How Arecor Therapeutics plc (6UI) stock performs in volatility spikes - 2025 Geopolitical Influence & Low Risk High Win Rate Picks - newser.com

How Arecor Therapeutics plc (6UI) stock performs in volatility spikes - 2025 Geopolitical Influence & Low Risk High Win Rate Picks newser.com

Creative Formulation: A Useful Approach to Patient-Centered Drug Development - BioProcess International

Creative Formulation: A Useful Approach to Patient-Centered Drug Development BioProcess International

Earnings Flash (AREC) Arecor Therapeutics Reports H1 Revenue GBP2.0M - MarketScreener

Earnings Flash (AREC) Arecor Therapeutics Reports H1 Revenue GBP2.0M MarketScreener

Lilly taps Arecor to develop self-administration formulation - Fierce Pharma

Lilly taps Arecor to develop self-administration formulation Fierce Pharma

Arecor presents positive data from phase I clinical trial of ultra-concentrated ultra-rapid acting insulin AT278 - Cambridge Network

Arecor presents positive data from phase I clinical trial of ultra-concentrated ultra-rapid acting insulin AT278 Cambridge Network

Arecor Therapeutics announces royalty financing agreement with Ligand to raise up to $11 mln - MarketScreener

Arecor Therapeutics announces royalty financing agreement with Ligand to raise up to $11 mln MarketScreener

Arecor Therapeutics, Intas Sign Formulation Agreement - Contract Pharma

Arecor Therapeutics, Intas Sign Formulation Agreement Contract Pharma

Arecor appoints Dr Helen Parris as Senior Vice President, Commercial And General Manager of Tetris Pharma Ltd - Cambridge Network

Arecor appoints Dr Helen Parris as Senior Vice President, Commercial And General Manager of Tetris Pharma Ltd Cambridge Network

Arecor CEO on AT278 partnership with Sequel Med Tech, $11m royalty funding deal and interim results - Proactive Investors

Arecor CEO on AT278 partnership with Sequel Med Tech, $11m royalty funding deal and interim results Proactive Investors

Sarah Howell, Arecor: “You build resilience you didn’t know you needed” - BGF

Sarah Howell, Arecor: “You build resilience you didn’t know you needed” BGF

Arecor announces update on INBRX-101 - Cambridge Network

Arecor announces update on INBRX-101 Cambridge Network

AIM Market Roundup: Wishbone, Nativo Resources, Arecor Therapeutics - The Armchair Trader

AIM Market Roundup: Wishbone, Nativo Resources, Arecor Therapeutics The Armchair Trader

Arecor Therapeutics signs exclusive licensing deal for AT351 in boost for Arestat platform - Cambridge Independent

Arecor Therapeutics signs exclusive licensing deal for AT351 in boost for Arestat platform Cambridge Independent

AIM movers: Bad drilling news from Pantheon Resources and third partnership for Arecor Therapeutics - UK Investor Magazine

AIM movers: Bad drilling news from Pantheon Resources and third partnership for Arecor Therapeutics UK Investor Magazine

Arecor Therapeutics subsidiary announces Netherlands roll-out of emergency-use diabetes pen - Proactive Investors

Arecor Therapeutics subsidiary announces Netherlands roll-out of emergency-use diabetes pen Proactive Investors

Arecor Therapeutics, Helium One Global, Kodal Minerals - Small Cap Snapshot - Proactive Investors

Arecor Therapeutics, Helium One Global, Kodal Minerals - Small Cap Snapshot Proactive Investors

Arecor Therapeutics: Dr Helen Parris - HealthInvestor UK

Arecor Therapeutics: Dr Helen Parris HealthInvestor UK

Arecor welcomes Helen Parris to new role at Tetris Pharma - Cambridge Independent

Arecor welcomes Helen Parris to new role at Tetris Pharma Cambridge Independent

JDRF and Arecor team to develop ultraconcentrated insulin - Fierce Pharma

JDRF and Arecor team to develop ultraconcentrated insulin Fierce Pharma

France, Congo-focused energy aspirant rattles the can - The Australian

France, Congo-focused energy aspirant rattles the can The Australian

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients - Cambridge Independent

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients Cambridge Independent

JDRF and Arecor to develop more concentrated insulin that could lead to smaller insulin pumps - diabetes.co.uk

JDRF and Arecor to develop more concentrated insulin that could lead to smaller insulin pumps diabetes.co.uk

Arecor Therapeutics (LON:AREC) Posts Quarterly Earnings Results - Defense World

Arecor Therapeutics (LON:AREC) Posts Quarterly Earnings Results Defense World

Arecor Therapeutics (LON:AREC) Stock Price Down 3.2% – What’s Next? - Defense World

Arecor Therapeutics (LON:AREC) Stock Price Down 3.2% – What’s Next? Defense World

Top Arecor Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant